Search Results - "Venkadakrishnan VB"

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.

Authors: Mizuno K Ku SY Venkadakrishnan VB et al.

Source: Nature communications [Nat Commun] 2025 Jul 01; Vol. 16 (1), pp. 5543. Date of Electronic Publication: 2025 Jul 01.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity.

Authors: Singh R Venkadakrishnan VB Imada E et al.

Source: Nature communications [Nat Commun] 2026 Feb 21; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 21.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Development of a prostate cancer biochemical recurrence risk signature using machine learning and motor protein-related genes.

Authors: Wang, Weixing Xie, Guohai Wu, Zhonggao

Source: PLoS ONE. 9/16/2025, Vol. 20 Issue 9, p1-17. 17p.

Decoding the germline genetic architecture of prostate cancer at a single cell resolution.

Authors: Wang, Cheng Tang, Tianqi Wang, Yuejun et al.

Source: PLoS Genetics. 12/30/2025, Vol. 21 Issue 12, p1-24. 24p.

B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape.

Authors: Van der Vreken, Arne Meeus, Fien Tu, Chenggong et al.

Source: Journal of Hematology & Oncology. 11/14/2025, Vol. 18 Issue 1, p1-17. 17p.

Transdifferentiation of Multiple Myeloma into Histiocytic Sarcoma: Case Report of a Highly Unusual Phenomenon.

Authors: Seth, Neha Naing, Phyu Thin Singh, Ram et al.

Source: Pathobiology. 2025, Vol. 92 Issue 6, p361-371. 11p.

Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer.

Authors: Chatterjee SS Linares JF Cid-Diaz T et al.

Source: Nature communications [Nat Commun] 2024 Nov 20; Vol. 15 (1), pp. 9755. Date of Electronic Publication: 2024 Nov 20.

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Epigenetic modifications in cancer drug resistance: molecular mechanisms and therapeutic interventions.

Authors: Yang J Zhang M Zhong Y et al.

Source: Molecular biomedicine [Mol Biomed] 2026 Apr 29; Vol. 7 (1). Date of Electronic Publication: 2026 Apr 29.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE

Growth hormone-secreting adenoma with lack of retinoblastoma protein expression.

Authors: Salvatori, Roberto Gallia, Gary L Lucas, Calixto-Hope G

Source: JCEM Case Reports. Jul2026, Vol. 4 Issue 7, p1-3. 3p.

Targeting the tumour cell surface in advanced prostate cancer.

Authors: Boixareu C Taha T Venkadakrishnan VB et al.

Source: Nature reviews. Urology [Nat Rev Urol] 2025 Sep; Vol. 22 (9), pp. 569-589. Date of Electronic Publication: 2025 Apr 01.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500082 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4820 (Electronic) Linking ISSN: 17594812 NLM ISO Abbreviation: Nat Rev Urol Subsets: MEDLINE

Elimination of docetaxel-induced senescence attenuates malignant progression in RB1-deficient CRPC.

Authors: Su, Huilan Huang, Liqun Xia, Wenwen et al.

Source: Cellular Oncology (2211-3428). Dec2025, Vol. 48 Issue 6, p2055-2072. 18p.

The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer.

Authors: Laudicella, Riccardo Bauckneht, Matteo Burger, Irene A et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2025, Vol. 52 Issue 7, p2723-2735. 13p.

Game of clones: decipher lineage plasticity in hormone-driven cancers.

Authors: Leonita A Cheng S Warrick J et al.

Source: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2026 Apr 22; Vol. 83 (1). Date of Electronic Publication: 2026 Apr 22.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE

Cancer and aging: complex associations and therapeutic targets.

Authors: Liang J Zang S Wang Z et al.

Source: Molecular biomedicine [Mol Biomed] 2026 Mar 31; Vol. 7 (1). Date of Electronic Publication: 2026 Mar 31.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE

Elucidating the anticancerous efficacy of genistein via modulating HPV (E7 and E6) oncogenes expression and apoptotic induction in cervical cancer cells.

Authors: Pandey, Pratibha Ramniwas, Seema Pandey, Shivam et al.

Source: Biotechnology & Applied Biochemistry. Jun2025, Vol. 72 Issue 3, p709-717. 9p.

Subjects: Tumor suppressor proteins, Apoptosis, Gene expression, Etiology of cancer, HeLa cells

DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers.

Authors: Li F Ling X Chakraborty S et al.

Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2026 May 18; Vol. 45 (1). Date of Electronic Publication: 2026 May 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [⁶⁸Ga]Ga-PSMA-11 PET scans of primary prostate cancer.

Authors: Rupp, Niels J. Freiberger, Sandra N. Ferraro, Daniela A. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Dec2024, Vol. 52 Issue 1, p305-313. 9p.

A Connection Between the Gut Microbiome and Epigenetic Modification in Age-Related Cancer: A Narrative Review.

Authors: Owens, Florida Souchak, Joseph Nazaire, Valeria et al.

Source: Aging & Disease. Feb2026, Vol. 17 Issue 1, p226-255. 30p.

Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor.

Authors: Obinata, Daisuke Takayama, Kenichi Lawrence, Mitchell G et al.

Source: BMC Cancer. 5/2/2024, Vol. 24 Issue 1, p1-12. 12p.

FVTF inhibits hepatocellular carcinoma stem properties via targeting DNMT1/miR-34a-5p/FoxM1 axis.

Authors: Cao, Xiao-Cheng Peng, Jinwu Qiu, Ye-Bei et al.

Source: Chinese Medicine. 3/6/2025, Vol. 20 Issue 1, p1-14. 14p.